Question 9 Sample Clauses

Question 9. The contract establishes a single fee dollar per hour for the CPFF Term CLINs and a single fee % for the CPFF completion CLINs for the life of the contract. Specifically concerning the fee dollar per hour amount: If there are significant variations in the labor mix of the task orders as compared to the labor mix from which the fee is calculated, this could introduce additional risk for the Offeror. Similarly, there is additional risk if task orders are not equally distributed across the period of performance. Would the government consider calculating the fee dollar per hour for each year of the contract instead of a single number for the entire period of performance? Answer 9: No, the Government is not making any changes to the fee calculation. The contract will have one fee dollar per hour for the CPFF Term CLINs and one fee percentage for the CPFF Completion CLINs.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Question 9. If you are affiliated with a broker-dealer, did you have any agreements or understandings, directly or indirectly, with any person to distribute the securities at the time that you purchased the securities? ANSWER: Yes No Please note that the Commission takes the position that if you are a broker-dealer, you are to be identified in the Registration Statement as an underwriter. In the “Plan of Distribution,” the Registration Statement will provide substantially as follows: “The selling stockholders and any broker-dealers, agents or underwriters that participate with the selling stockholders in the distribution of the issued and outstanding shares of common stock or the shares of stock issuable upon exercise of warrants may be deemed to be “underwriters” within the meaning of the Securities Act, in which event any commissions received by these broker-dealers, agents or underwriters and any profits realized by the selling stockholders on the resales of the securities may be deemed to be underwriting commissions or discounts under the Securities Act. If the selling stockholders are deemed to be underwriters, the selling stockholders may be subject to certain statutory and regulatory liabilities, including liabilities imposed pursuant to Sections 11, 12 and 17 of the Securities Act and Rule 10b-5 under the Exchange Act.” QUESTION 10: Are their specific individuals who have voting or investment control over the securities? ANSWER: Yes No If you answered “yes”, please list the names of such individuals: The answers to the foregoing questions are true and correct to the best of the undersigned’s knowledge, information and belief. The undersigned agrees to promptly notify the Company in writing in care of Chief Financial Officer, InSite Vision Incorporated, 000 Xxxxxxxx Xxxxxx, Xxxxxxx, Xxxxxxxxxx 00000 of (a) any transfer by you of your Units, (b) sales of common stock of the Company (giving the number of shares sold and the name of the broker-dealer used) and (c) any other changes in the answers to this questionnaire that should be made as a result of any material development occurring subsequent to the date hereof. Dated: , 2004.
Sample 1
Question 9. Who do you believe to be the Critics/Sceptics in relation to H2 Powered Transport and Why are they Critics/Sceptics? % of Responses Nominating Category as Sceptics/Critics of H2 (N=58) Government/Officials Current Energy Producers (Elect./Oil) Environmental Groups Other Alternative Energy Lobby Some OEM's/Lobby Scientists 0 25 30 In an effort to broaden the base of individuals interviewed, interviewees were asked to nominate others whom they saw as critics and sceptics of the use of H2 in transport. It was noteworthy that some of the individuals/organisations that were nominated, when interviewed, did not see themselves as either critics or sceptics and were surprised to hear they had been identified as such.
Sample 1
Question 9. What additional costs may be incurred by you or those you represent as a result of implementing the AIHTS requirements for manufacturers? (For example, include costs incurred in relation to the alteration of designs and instructions and provision of suitable identification). Please quantify additional costs in £ Question 10: What additional training costs may be incurred by you or those you represent as a result of implementing the AIHTS? Please quantify additional cost in £ Question 11: Which make and models of stoat trap and how many do you or those you represent use? Make and model Number used BMI Magnum 110 BMI Magnum 116 Conibear 110-2 Conibear 120-2 DOC 150 DOC 200 DOC 250 Xxxx XX I Xxxx XX II Xxxx XX III Xxxx MKIV Xxxx MKVI Xxxxxxxxxx A24 Imbra MKI Imbra MKII Xxxx Xxxxx Trap 2000 Xxxxx Trap 2500 Xxxxx Xxxxxx Solway MK4 Solway MK6 Springer No. 4 Springer No. 6 WCS Tube Trap Cage-trap Other (please specify) Other (please specify) Question 12: Roughly how many of each permitted target species do you catch using these traps in an average year? Please give the total number of permitted target species caught per make and model (not the number caught per individual trap). Make and model Stoat Weasel Grey Squirrel Mink Rabbit Rat Mouse Edible Dormouse Other BMI Magnum 110 BMI Magnum 116 Conibear 110-2 Conibear 120-2 DOC 150 DOC 200 DOC 250 Xxxx XX I Xxxx XX II Xxxx XX III Xxxx MKIV Xxxx MKVI Xxxxxxxxxx A24 Imbra MKI Imbra MKII Xxxx Xxxxx Trap 2000 Xxxxx Trap 2500 Make and model Stoat Weasel Grey Squirrel Mink Rabbit Rat Mouse Edible Dormouse Other Xxxxx Xxxxxx Solway MK4 Solway MK6 Springer No. 4 Springer No. 6 WCS Tube Trap Cage-trap Other (please specify) Other (please specify) Question 13: How often in years do you or those you represent replace a particular make and model of trap (how long is its working life)? Please do not include traps that YOU or those you represent have but no longer use. Make and model Working Life of Trap BMI Magnum 110 BMI Magnum 116 Conibear 110-2 Conibear 120-2 DOC 150 DOC 200 DOC 250 Xxxx XX I Xxxx XX II Xxxx XX III Xxxx MKIV Xxxx MKVI Xxxxxxxxxx A24 Imbra MKI Imbra MKII Xxxx Xxxxx Trap 2000 Xxxxx Trap 2500 Xxxxx Xxxxxx Solway MK4 Solway MK6 Springer No. 4 Springer No. 6 WCS Tube Trap Cage-trap Other (please specify) Other (please specify) The purpose of the following questions is to estimate the average numbers of animals (other than stoat – see Q12) listed on AIHTS that are trapped each year and identify the traps used. Tho...
Sample 1

Related to Question 9

  • QUESTIONS All questions or concerns regarding this Invitation for Bids shall be submitted by email to Xxxxxxx.Xxxxxxx@xxxx.xxx, no later than 5:00 PM Thursday, May 26, 2022 to the attention of Xxxxxxx Xxxxxxx, Procurement Division, referencing the IFB number. TABLE OF CONTENTS DESCRIPTION PAGE SECTION 1: GENERAL TERMS AND CONDITIONS GENERAL TERMS AND CONDITIONS 3-19 SECTION 2: SPECIAL TERMS AND CONDITIONS SPECIAL TERMS AND CONDITIONS 20-31 SECTION 3: SPECIFICATIONS/SCOPE OF SERVICES SPECIFICATIONS/SCOPE OF SERVICES 32-36 SECTION 4: BID SUBMISSION REQUIREMENTS AND DOCUMENTATION - QUALIFICATION OF BIDDERS (BID PACKAGE REQUIREMENTS) - BID RESPONSE FORM - EMERGENCY CONTACTS - ACKNOWLEDGEMENT OF ADDENDA - AUTHORIZED SIGNATORIES/NEGOTIATORS - REFERENCE DOCUMENTATION FORM - DRUG-FREE WORKPLACE FORM - SCHEDULE OF SUBCONTRACTING FORM - CONFLICT/NON-CONFLICT OF INTEREST FORM - E-VERIFICATION CERTIFICATION - RELATIONSHIP DISCLOSURE FORM - RELATIONSHIP DISCLOSURE FORM - FREQUENTLY ASKED QUESTIONS (FAQ) - ORANGE COUNTY SPECIFIC PROJECT EXPENDITURE REPORT - EXPENDITURE REPORT- FREQUENTLY ASKED QUESTIONS (FAQ) - AGENT AUTHORIZATION FORM - LEASED EMPLOYEE AFFIDAVIT - INFORMATION FOR DETERMINING JOINT VENTURE ELIGIBILITY - CONTRACT - ATTACHMENT A - DIRECTIONS TO ORANGE COUNTY CONVENTION CENTER - ATTACHMENT B – PARKING PASS SECTION 1 GENERAL TERMS AND CONDITIONS

  • Challenges The Experts may be challenged by either Party if circumstances exist that give rise to justifiable doubts as to any of their impartiality or independence. In such circumstances the challenge shall be brought by written notice to the ICC copied to the other Party within fourteen (14) calendar days of the appointment of the relevant Expert or within fourteen (14) calendar days of the challenging Party becoming aware of the circumstances giving rise to the challenge. Unless the challenged Expert withdraws. or whichever of the Parties that has not brought the challenge agrees to the challenge, within fourteen (14) calendar days of the challenge, the ICC shall decide the challenge and, if appropriate, shall appoint a replacement Expert in accordance with the criteria set out herein.

  • Arbitrability Issues of arbitrability shall be bifurcated from the substantive issue(s) and, whenever possible, determined by means of a hearing conducted by conference call. The arbitrator shall have ten (10) days from the hearing to render a decision on arbitrability. If the issue is judged to be arbitrable, an arbitrator shall then be selected to hear the substantive issue(s).

  • Challenge If Executive violates or challenges the enforceability of any provisions of the Restrictive Covenants or this Release, no further payments, rights or benefits under Section 5 of the Agreement will be due to Executive (except where such provision would be prohibited by applicable law, rule or regulation).

  • Questions About Review The Asset Representations Reviewer will make appropriate personnel available to respond in writing to written questions or requests for clarification of any Review Report from the Indenture Trustee or the Servicer until the earlier of (i) the payment in full of the Notes and (ii) one year after the delivery of the Review Report. The Asset Representations Reviewer will not be obligated to respond to questions or requests for clarification from a Noteholder or any other Person and will direct such Persons to submit written questions or requests to the Indenture Trustee.

  • Dispute a. In the event of any dispute whatsoever in respect of the sale, the Purchaser hereby expressly agrees to resolve the same with the Assignee.

  • CONCERNING BNY 1. BNY shall not be liable for any costs, expenses, damages, liabilities or claims, including attorneys' and accountants' fees, sustained or incurred by, or asserted against, the Fund except to the extent the same arises out of the failure of BNY to exercise the care, prudence and diligence required by Section 2 of Article II hereof. In no event shall BNY be liable to the Fund, the Board, or any third party for special, indirect or consequential damages, or for lost profits or loss of business, arising in connection with this Agreement.

  • Outcome a desirable situation, condition, or circumstance in a member’s life that can be a result of the support provided by effective care management. Outcomes defined include:

  • Grievability Denial of a petition for reinstatement is grievable. The grievance may not be based on information other than that shared with the Employer at the time of the petition for reinstatement.

  • No Challenges Each Shareholder agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub, the Company or any of their respective successors or directors (a) challenging the validity of, or seeking to enjoin the operation of, any provision of this Agreement or the Merger Agreement or (b) alleging a breach of any fiduciary duty of any person in connection with the evaluation, negotiation or entry into the Merger Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.